References
- Valent P, Klion AD, Horny HP, et al. Contempory consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012;130:607–612.
- Leblond P, Lepers S, Thebaud E, et al. Le syndrome d'hyperéosinophilie essentielle: à propos d'un cas chez un nourrisson. Arch Pediatr 2004;11:219–222.
- van Grotel M, de Hoog M, de Krijger RR, et al. Hypereosinophilic syndrome in children. Leuk Res 2012;36:1249–1254.
- Rapanotti MC, Caruso R, Ammatuna E, et al. Molecular characterization of paediatric idiopathic hypereosinophilia. Br J Haematol 2010;151:440–446.
- Farruggia P, Giugliano E, Russo D, et al. FIP1L1-PDGFRα-positive hypereosinophilic syndrome in cxhildhood: a case report and review of literature. J Pediatr Hematol Oncol 2014;36:e28–e30.
- Keivanidou A, Giannopoulos A, Papageorgiou T, et al. Loeffler endocarditis in a pediatric pati ent. Pediatr Hematol Oncol 2014; 31:375–379.
- Ogbogu P, Rosing DR, Mc Donald K. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007;27:457–475.
- Cogan E, Roufosse F. Clinical management of the hypereosinophilic syndromes. Expert Rev Hematol 2012;5:275–290.
- Gotlib J. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management. Am J Hematol 2014;89:325–337.
- Mehr S, Rego S, Kakakios A, et al. Treatment of a case of pediatric hypereosinophilic syndrome with anti-interleukin-5. J Pediatr 2009;155:289–291.
- Fathi AT, Dec GW Jr, Richter JM, et al. Case records of the Massachusetts General Hospital. Case 7-2014. A 27-year-old man with diarrhea, fatigue, and eosinophilia. N Engl J Med 2014 27; 370:861–872.
- Juvonen E, Volin L, Koponen A, et al. Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome. Bone Marrow Transplant 2002; 29:457–458.
- Ueno NT, Anagnostopoulos A, Rondón G, et al. Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome. Br J Haematol 2002;119:131–134.
- Bergua JM, Prieto-Pliego E, Román-Barberá A, et al. Resolution of left and right ventricular thrombosis secondary to hypereosinophilic syndrome (lymphoproliferative variant) with reduced intensity conditioning allogenic stem cell transplantation. Ann Hematol 2008;87:937–938.
- Nishioka C1, Ikezoe T, Yang J, et al. Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway. Leukemia 2007; 21:1044–1049.